Toronto Dominion Bank
EVGN icon

Toronto Dominion Bank’s Evogene EVGN Stock Holding History

Toronto Dominion Bank’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2
Closed -$130 – 1243
2024
Q2 		$130 Hold
2
– – ﹤0.01% 1339
2024
Q1 		$15 Hold
2
– – ﹤0.01% 1393
2023
Q4 		$17 Hold
2
– – ﹤0.01% 1545
2023
Q3 		$12 Buy
+2
New +$18 ﹤0.01% 1803

Other funds holding EVGN

SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
RIG
Renaissance Investment Group Lenox, Massachusetts $508M AUM 30.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Toronto Dominion Bank's EVGN Position: Q3 2024 in Review

Toronto Dominion Bank sold out of Evogene (EVGN) in Q3 2024, closing a stake of 2 shares — an estimated $130 sold.

Toronto Dominion Bank first reported a position in EVGN in Q3 2023 and held it in 4 quarters. The position peaked at $130 in Q2 2024. 14 funds tracked by Wall St. Rank hold EVGN as of Q3 2024.

  • Toronto Dominion Bank reported no remaining Evogene position as of Q3 2024 after selling out during the quarter.
  • Toronto Dominion Bank sold 2 Evogene shares in Q3 2024, an estimated $130.
  • Toronto Dominion Bank first reported a position in Evogene in Q3 2023 and held it in 4 quarters.
  • Toronto Dominion Bank's Evogene position peaked at $130 in Q2 2024.
  • 14 funds tracked by Wall St. Rank held Evogene as of Q3 2024.

Based on Toronto Dominion Bank's 13F filing for Q3 2024, filed 14 Nov 2024.